Vizient Clinical Data Base Offers Insights into CAR-T and Bone Marrow Transplants at 2019 Transplantation & Cellular Therapy Meeting of ASBMT and CIBMTR
Summary
Vizient will present four posters at the event which is focused on recent progress in basic science, translational research and clinical studies in all areas of blood and marrow transplantation and cellular therapy. It describes trends in adult patient populations, outcomes, and adverse events using the CAR-T procedure codes in administrative data. The poster examines the top drivers of cost for more than 5,500 bone marrow extraction encounters in the inpatient and outpatient setting in 2017 using the Vizient CDB/RM. The analysis includes a review of advanced practice provider roles, patient demographics, and encounter characteristics. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as MedAssets’ Spend and Clinical Resource Management (SCM) segment, including Sg2, which was acquired in 2016.